{"filings":[{"id":2263636,"accession_number":"0001816708-26-000092","cik":1816708,"company_name":"Owlet, Inc.","ticker":"OWLT","form_type":"8-K","filed_at":"2026-08-14T16:56:08+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"Owlet shareholders approve 600k share plan increase; reelect two Class II directors","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["At Aug 12, 2026 annual meeting, stockholders approved Amendment No. 3 adding 600,000 shares to 2021 Incentive Award Plan.","Marc F. Stoll and Kurt Workman re-elected as Class II directors until 2029; 17.35M and 17.36M votes for, respectively.","Non-binding say-on-pay approved with 17.47M for; shareholders chose annual frequency (20.10M votes for 1 year).","PricewaterhouseCoopers ratified as FY2026 auditor with 22.56M for; record date June 15, 2026 with 29.06M shares outstanding.","Series A and B preferred stockholders voted unanimously to approve plan amendment as separate classes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":166176689.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":2189918,"accession_number":"0001816708-26-000082","cik":1816708,"company_name":"Owlet, Inc.","ticker":"OWLT","form_type":"8-K","filed_at":"2026-08-11T20:16:29+00:00","items":["2.02","9.01"],"status":"ready","headline":"Owlet Q2 2026: Record revenue $33.9M (+29.9%), net loss narrows to $0.6M, raises adjusted EBITDA guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 revenue $33.9M vs $26.1M YoY; subscription revenue $3.2M vs $0.9M YoY.","Net loss $0.6M vs $37.4M; GAAP gross margin 64.4%, ex-tariff 54.0% (+270bps).","Adjusted EBITDA $6.7M incl. $3.75M tariff refund; ex-refund $2.9M vs $0.5M.","Adjusted EPS $0.20 vs -$0.04; GAAP EPS -$0.05 vs -$2.35.","FY2026 guidance: revenue $118-122M; gross margin 53-55%; adjusted EBITDA $10.75-12.75M (both raised on tariff refund)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":166176689.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1369797,"accession_number":"0001816708-26-000069","cik":1816708,"company_name":"Owlet, Inc.","ticker":"OWLT","form_type":"8-K","filed_at":"2026-07-01T11:12:38+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Owlet secures $25M Wells Fargo credit facility, cuts borrowing cost by at least 525 bps","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["New $25M asset-based revolving credit facility with Wells Fargo, maturing June 2029.","Interest rate margin reduced to SOFR+2.00-2.25% from prior SOFR+7.50-8.50%.","Total liquidity of ~$33.8M as of June 26, 2026, including cash and undrawn capacity.","Facility can be increased to $35M subject to lender approval; refinances existing ABL and term loans.","Covenants include minimum $7.5M liquidity and specified EBITDA thresholds."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":166176689.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":890316,"accession_number":"0001816708-26-000055","cik":1816708,"company_name":"Owlet, Inc.","ticker":"OWLT","form_type":"8-K","filed_at":"2026-06-05T20:59:20+00:00","items":["8.01"],"status":"ready","headline":"Owlet postpones 2026 Annual Meeting to Aug 12 due to scheduling conflicts","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Annual Meeting rescheduled from July 10 to August 12, 2026, at 1:00 p.m. ET via remote communication.","New record date for voting is June 15, 2026.","Deadline for stockholder proposals (including Rule 14a-8) is June 15, 2026.","Reason cited: scheduling conflicts with no further details provided."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":166176689.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":95712,"accession_number":"0001816708-26-000041","cik":1816708,"company_name":"Owlet, Inc.","ticker":"OWLT","form_type":"8-K","filed_at":"2026-05-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Owlet Q1 revenue $22.5M (+6.4% YoY); net loss $3.3M vs income $3.0M; cuts FY revenue guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 revenue $22.5M (+6.4% YoY); subscription revenue record $2.7M; subscribers over 115k.","Net loss $3.3M ($0.15 loss per share) vs net income $3.0M ($0.11 EPS) in Q1 2025.","Adjusted EBITDA -$1.5M vs $0.0M; gross margin 54.5% (+80 bps) despite tariff impacts.","FY 2026 revenue guidance lowered to $118-122M (prev $126-130M); adj. EBITDA guidance raised to $7-9M (prev $3-5M).","Co-founder Kurt Workman reassumes CEO role; sharpening focus on margin and operating efficiency."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.25,"consensus_revenue_estimate":null,"consensus_revenue_actual":22456000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":166176689.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":95711,"accession_number":"0001816708-26-000023","cik":1816708,"company_name":"Owlet, Inc.","ticker":"OWLT","form_type":"8-K","filed_at":"2026-04-06T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Owlet appoints Kurt Workman as President and CEO, succeeds Jonathan Harris","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Kurt Workman appointed President and CEO effective April 6, 2026, succeeds Jonathan Harris.","Workman will cease as Executive Chairman but remain a director; Harris separation includes 12 months base salary ($500,000), prorated 2026 bonus, and full equity vesting.","Workman receives $500,000 base salary, 70% target annual bonus, and 850,000 RSU grant under 2021 Incentive Award Plan.","Workman is Tier 1 participant in Executive Change in Control Severance Plan with 12-month severance and accelerated vesting upon qualifying termination."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":166176689.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":108978,"accession_number":"0001816708-26-000011","cik":1816708,"company_name":"Owlet, Inc.","ticker":"OWLT","form_type":"8-K","filed_at":"2026-03-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Owlet reports record FY 2025 revenue of $105.7M, initiates 2026 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2025 revenue $26.6M (+29.6% YoY); gross margin 47.6%; net loss $9.2M ($0.39/share).","FY 2025 record revenue $105.7M (+35.4% YoY); record gross margin 50.6%; record adjusted EBITDA $2.0M.","FY 2025 net loss $39.7M includes $26.6M non-cash warrant liability adjustment; operating loss narrowed to $8.3M.","Q1 2026 revenue guidance $20-21M; FY 2026 revenue guidance $126-130M (19-23% growth); Owlet360 subscribers exceed 110,000."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":166176689.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":108977,"accession_number":"0001816708-26-000004","cik":1816708,"company_name":"Owlet, Inc.","ticker":"OWLT","form_type":"8-K","filed_at":"2026-02-05T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Owlet derivative suit settlement hearing moved to Feb 25; governance reforms proposed","summary_kind":"llm","event_type":"litigation","confidence":"high","bullets":["Hearing on settlement of Vargas v. Workman derivative action continued from Feb 6 to Feb 25, 2026.","Settlement requires Owlet to adopt corporate governance reforms for at least 8 years, including new Audit/Risk, ERM, and Disclosure committees.","No monetary relief to shareholders; plaintiffs' counsel will seek court-approved fees and expenses from Owlet.","Reforms are intended to strengthen internal controls, risk management, and disclosure accuracy post-SEC issues.","Settlement was reached after arm's-length negotiations; Owlet denies any wrongdoing but agrees to reforms."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":166176689.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":125433,"accession_number":"0001816708-25-000060","cik":1816708,"company_name":"Owlet, Inc.","ticker":"OWLT","form_type":"8-K","filed_at":"2025-11-13T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Owlet reports record Q3 revenue $32M (+44.6%), net income $4.1M; raises FY25 guidance to $103-106M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $32.0M (record), up 44.6% YoY; gross margin 50.6% (down 150bps from tariffs).","Operating income $1.2M (record, vs loss of $4.8M); net income $4.1M (record, vs loss of $5.6M).","Adjusted EBITDA $1.6M (record), improving $1.0M YoY.","Owlet360 subscribers surpass 85,000; intl. expansion +171% YoY; India clearance for 2026 launch.","FY25 guidance raised: revenue $103-106M (32-36% growth), adjusted EBITDA $1.25-2M."],"consensus_eps_estimate":null,"consensus_eps_actual":-2.03,"consensus_revenue_estimate":null,"consensus_revenue_actual":79155000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":166176689.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":125432,"accession_number":"0001628280-25-045943","cik":1816708,"company_name":"Owlet, Inc.","ticker":"OWLT","form_type":"8-K","filed_at":"2025-10-23T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Owlet prelim Q3 revenue $30-32M (up 36-45% YoY); gross margin 49.5-51%; launches $30M stock offering","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue for Q3 2025 estimated $30M-$32M vs $22.1M in Q3 2024 (approx. 36-45% YoY growth).","Gross margin estimated 49.5%-51% vs 52.2% in prior year, decline attributed to tariffs.","Cash and equivalents ~$23.8M including $18.6M additional borrowings under credit facility during Q3.","Underwriting agreement to sell 4.196M shares at $7.15/sh; proceeds for commercialization, R&D, general corporate.","Underwriters have 30-day option to purchase up to 629,400 additional shares; 90-day lock-up for insiders."],"consensus_eps_estimate":null,"consensus_eps_actual":-2.03,"consensus_revenue_estimate":null,"consensus_revenue_actual":79155000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":166176689.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":125431,"accession_number":"0001816708-25-000044","cik":1816708,"company_name":"Owlet, Inc.","ticker":"OWLT","form_type":"8-K","filed_at":"2025-10-14T23:59:59+00:00","items":["5.02","5.03","5.07","8.01","9.01"],"status":"ready","headline":"Owlet completes warrant exchange issuing 5.4M shares; stockholder meeting approves plan and charter changes","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Stockholders approved issuance of 5,426,429 common shares in exchange for 9,014,758 warrants; exchange consummated Oct 10, 2025.","Outstanding common shares increased to 22,788,420 after the exchange.","Stockholders approved a 375,000-share increase to the 2021 Incentive Award Plan.","Charter amendment approved to provide officer exculpation under Delaware law.","Directors elected: Zane M. Burke, John C. Kim, Melissa A. Gonzales for Class I."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":166176689.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":125430,"accession_number":"0001816708-25-000040","cik":1816708,"company_name":"Owlet, Inc.","ticker":"OWLT","form_type":"8-K","filed_at":"2025-10-06T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Owlet appoints Jonathan Harris as CEO; Workman becomes Executive Chair","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Kurt Workman resigns as CEO, transitions to Executive Chair effective Oct 1, 2025.","Jonathan Harris appointed President and CEO; base salary $500k, bonus target 70% of salary.","Workman receives accelerated vesting of 95,741 RSUs and $200k cash retainer as Executive Chair.","Amended director comp program sets Executive Chair retainer at $200k cash + $200k equity annually.","Harris enters amended offer letter with severance of 12 months base salary, prorated bonus, equity vesting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":166176689.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142168,"accession_number":"0001816708-25-000036","cik":1816708,"company_name":"Owlet, Inc.","ticker":"OWLT","form_type":"8-K","filed_at":"2025-09-24T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Owlet settles derivative lawsuit over Smart Sock statements, agrees to governance reforms","summary_kind":"llm","event_type":"litigation","confidence":"high","bullets":["Court preliminarily approved settlement of derivative action Vargas v. Workman on Sept 11, 2025.","Company to adopt governance reforms including Audit & Risk, ERM, and Disclosure Committees for at least 8 years.","No admission of wrongdoing; company to pay attorney's fees (amount not yet determined).","All derivative claims dismissed with prejudice upon final court approval."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":166176689.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142165,"accession_number":"0001816708-25-000032","cik":1816708,"company_name":"Owlet, Inc.","ticker":"OWLT","form_type":"8-K/A","filed_at":"2025-08-13T23:59:59+00:00","items":["9.01","1.01","3.02"],"status":"ready","headline":"Owlet exchanges warrants for 5.43M new shares; stockholder approval required","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Exchange of up to 9,014,758 warrant shares for 5,426,429 new common shares; stockholder approval required at 2025 annual meeting.","Holders include Eclipse (29% voting rights), Trilogy (6.7%), CEO Kurt Workman, and director John Kim.","Exchanged shares subject to 180-day lock-up; registration rights to be filed within 30 days of closing.","If closing not by November 5, 2025, either party may terminate the agreement.","Transaction approved by a special committee of disinterested and independent directors."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":166176689.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142167,"accession_number":"0001816708-25-000020","cik":1816708,"company_name":"Owlet, Inc.","ticker":"OWLT","form_type":"8-K","filed_at":"2025-08-07T23:59:59+00:00","items":["2.02","9.01","5.02"],"status":"ready","headline":"Owlet Q2 revenue $26.1M (+26% YoY), raises FY2025 guidance; announces CEO transition","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 revenue $26.1M, up 25.9% YoY; gross margin 51.3%, up 180 bps.","Net loss $37.6M includes $34.8M non-cash warrant adjustment; adjusted EBITDA $0.3M vs $0.1M prior year.","Full-year 2025 revenue guidance raised to $97-100M (24-28% growth); expects adjusted EBITDA profitable.","CEO Kurt Workman steps down Oct 1, 2025; becomes Executive Chairman; President Jonathan Harris becomes CEO.","Owlet360 subscription surpasses 66,000 paying subscribers with steady growth."],"consensus_eps_estimate":null,"consensus_eps_actual":-2.26,"consensus_revenue_estimate":null,"consensus_revenue_actual":47167000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":166176689.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142166,"accession_number":"0001816708-25-000019","cik":1816708,"company_name":"Owlet, Inc.","ticker":"OWLT","form_type":"8-K","filed_at":"2025-08-07T23:59:59+00:00","items":["1.01","3.02"],"status":"ready","headline":"Owlet swaps warrants for 5.4M new common shares; requires stockholder approval","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Exchanges Series A warrants (7,215,737 shares) and Series B warrants (1,799,021 shares) for 5,426,429 new common shares.","Holders include Eclipse (29% voting power), Trilogy (6.7%), CEO Kurt Workman, and director John Kim.","Exchanged shares subject to 180-day lock-up; company to file resale registration within 30 days after close.","Exchange requires stockholder approval at 2025 annual meeting; holders agree to vote in favor.","Valuation determined using Black-Scholes with trailing 60-day VWAP and realized volatility."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":166176689.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":160163,"accession_number":"0001628280-25-031614","cik":1816708,"company_name":"Owlet, Inc.","ticker":"OWLT","form_type":"8-K","filed_at":"2025-06-16T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Owlet amends credit facility; eases financial covenants and expands borrowing base","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Minimum TTM EBITDA relaxed: $(3.9M) at Dec 2024, $(4.8M) at Mar 2025, rising to $6.5M by Dec 2026.","Capital expenditure limits increased to $500k (FY2024), $1.5M (FY2025), $2.0M (FY2026) with 50% carryforward.","Eligible accounts expanded: certain non-US account debtors now eligible up to $3M aggregate and $3M per debtor limit.","Amendment effective retroactively to December 31, 2024; loan parties released all claims against lenders."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":166176689.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":160162,"accession_number":"0001628280-25-023770","cik":1816708,"company_name":"Owlet, Inc.","ticker":"OWLT","form_type":"8-K","filed_at":"2025-05-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Owlet Q1 revenue $21.1M (+43% YoY); raises FY2025 revenue guidance to $91-95M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 revenue $21.1M, up 43.1% YoY; gross margin 53.7%, up 930 bps to 53.7%.","Adjusted EBITDA breakeven vs -$3.1M a year ago; fourth consecutive quarter at or above breakeven.","Net income $3.0M includes $6.7M warrant gain; adjusted net loss per share improved to $0.07 from $0.39.","FY2025 revenue guidance raised to $91-95M (17-22% growth); gross margin 46-50% including tariffs.","Owlet360 reaches 48,000 paying subscribers; new hospital distribution partnership with Children's Hospital of The King's Daughters."],"consensus_eps_estimate":null,"consensus_eps_actual":0.11,"consensus_revenue_estimate":null,"consensus_revenue_actual":21104000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":166176689.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":178475,"accession_number":"0001628280-25-009814","cik":1816708,"company_name":"Owlet, Inc.","ticker":"OWLT","form_type":"8-K","filed_at":"2025-03-04T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Owlet Q4 revenue $20.5M, gross margin 53.5%; FY2024 rev up 45% to $78.1M; guides FY2025 rev $88-92M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $20.5M (down 2% YoY but up 37% adjusting for Amazon partner shift); gross margin 53.5% (+650 bps).","Q4 adjusted EBITDA positive $0.5M, improving $1.2M YoY; net loss $9.1M vs $6.9M.","FY2024 revenue $78.1M (+45%); gross margin 50.4% (+850 bps); net loss $12.5M vs $32.9M.","FY2025 guidance: revenue $88-92M, gross margin 50-52%, targeting full-year adjusted EBITDA profitability.","Launched Owlet360 subscription service leveraging pediatric health data for personalized insights."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":166176689.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":195148,"accession_number":"0001628280-24-047594","cik":1816708,"company_name":"Owlet, Inc.","ticker":"OWLT","form_type":"8-K","filed_at":"2024-11-13T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Owlet Q3 revenue up 141% to $22.1M; adj. EBITDA positive $0.6M; raises FY2024 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $22.1M (+141% YoY); gross margin 52.2% (up 1,590 bps).","Net loss $(5.6)M flat YoY; adjusted net income per share $0.03 vs $(0.70) loss.","Adjusted EBITDA $0.6M vs $(5.5)M loss in Q3 2023, an improvement of $6.1M.","Full-year 2024 guidance raised: revenue $74-77.5M, gross margin 48-49%, adjusted EBITDA loss $(5)-(3)M.","Completed equity offering and debt refinancing in Q3 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.79,"consensus_revenue_estimate":null,"consensus_revenue_actual":57571000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":166176689.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":195147,"accession_number":"0001628280-24-047263","cik":1816708,"company_name":"Owlet, Inc.","ticker":"OWLT","form_type":"8-K","filed_at":"2024-11-12T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"Owlet amends bylaws to adopt universal proxy rules and enhance stockholder nomination procedures","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Amendments address SEC universal proxy rules by requiring compliance with Rule 14a-19.","Enhanced disclosure requirements for stockholder director nominations and other business proposals.","Proxy card color other than white mandated for non-Board solicitations; white reserved for Board.","Amendments effective November 7, 2024; also include modernizing and clarifying changes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":166176689.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":211419,"accession_number":"0001628280-24-040375","cik":1816708,"company_name":"Owlet, Inc.","ticker":"OWLT","form_type":"8-K","filed_at":"2024-09-13T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Owlet raises ~$11.6M via 3.14M share offering at $3.70; issues underwriter warrant","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Gross proceeds ~$11.6M from sale of 3,135,136 shares of Class A common at $3.70 per share.","Concurrent private placement: warrant to purchase up to 125,405 shares at $4.63, exercisable from March 13, 2025, for 5 years.","Underwriting agreement with Titan Partners Group LLC; closing on September 13, 2024.","Lock-up: directors/officers/stockholders for 90 days; warrant holder lock-up for 180 days.","Shares issued under effective S-3 registration statement (333-281556); final prospectus filed Sep 12."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":166176689.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":211418,"accession_number":"0001628280-24-040154","cik":1816708,"company_name":"Owlet, Inc.","ticker":"OWLT","form_type":"8-K","filed_at":"2024-09-11T23:59:59+00:00","items":["1.01","2.03","3.02","9.01"],"status":"ready","headline":"Owlet refinances SVB debt, enters new $15M ABL revolver and $15M WTI loan facility","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Enters $15M asset-based revolving credit facility (increases to $20M after 1 yr); SOFR +7.5%-8.5%, matures Sept 2027.","Enters $15M WTI term loan facility: $10M first tranche, $5M second tranche conditional on revenue/burn metrics; Prime+3.5% (floor 12%) plus 2.5% PIK.","Issues 750,000 shares of common stock to WTI as partial consideration; put option at $8.40/share after 5 years.","Uses existing cash to repay and extinguish all outstanding SVB line of credit and term loan borrowings.","Initiates $7.5M draw under WTI facility, subject to funding conditions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":166176689.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":211417,"accession_number":"0001628280-24-038209","cik":1816708,"company_name":"Owlet, Inc.","ticker":"OWLT","form_type":"8-K","filed_at":"2024-08-22T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"Owlet stockholders elect directors, approve 400k share increase to incentive plan","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Elected Laura J. Durr, Amy N. McCullough, Lior Susan as Class III directors with >8.7M votes each.","Amendment to 2021 Incentive Award Plan approved; 400,000 additional shares authorized for issuance.","Ratified PwC as independent auditor for FY2024: 10,304,205 for, 368,853 against, 21,403 abstentions.","Broker non-votes of 1,528,016 on director election and plan amendment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":166176689.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":211416,"accession_number":"0001628280-24-038103","cik":1816708,"company_name":"Owlet, Inc.","ticker":"OWLT","form_type":"8-K","filed_at":"2024-08-22T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Owlet preferred holders convert shares; market cap ~$54M, addressing NYSE compliance","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["15,721 Series A preferred shares converted into 2,291,686 Class A common shares.","Post-conversion outstanding: 11,710,310 common, 11,479 Series A, 9,250 Series B shares.","Conversion is part of effort to regain NYSE $50M market cap requirement; market cap ~$54M as of Aug 21 close.","Holders cited positive business progress and capital structure simplification as conversion reasons."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":166176689.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":211415,"accession_number":"0001628280-24-036778","cik":1816708,"company_name":"Owlet, Inc.","ticker":"OWLT","form_type":"8-K","filed_at":"2024-08-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Owlet Q2 revenue up 58% to $20.7M, adjusted EBITDA turns positive at $0.1M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue of $20.7M, up 58% YoY; gross margin 50%, up ~1,000 bps from 2023.","Net loss narrowed to ($1.1M) from ($8.5M); adjusted EBITDA of $0.1M vs loss of ($4.3M).","CE Medical certification obtained; Dream Sock launched in UK and EU markets.","FY 2024 revenue guidance $72.5M–$77.5M; adjusted EBITDA loss of ($6M)–($3M).","Record-breaking Amazon Prime Day performance cited for Q3 momentum."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.08,"consensus_revenue_estimate":null,"consensus_revenue_actual":35449000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.73,"calibrated_materiality_score":0.73,"market_cap_usd":166176689.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":211414,"accession_number":"0001628280-24-031526","cik":1816708,"company_name":"Owlet, Inc.","ticker":"OWLT","form_type":"8-K","filed_at":"2024-07-09T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Owlet appoints Amanda Twede Crawford as CFO; Kate Scolnick departs; reaffirms 2024 goals","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Amanda Twede Crawford promoted from VP FP&A to CFO effective July 9, 2024; Kate Scolnick to stay in advisory role through September 2024.","Scolnick's separation agreement includes six months base salary and bonus ($9,014/week), accelerated equity vesting, and COBRA reimbursement.","Crawford's compensation: $300,000 base salary, 35% bonus target, and equity award between $200k-$300k RSUs pending board approval.","CEO reaffirms 2024 financial goals including progress toward adjusted EBITDA breakeven; Q2 2024 earnings call August 12, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":166176689.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":230049,"accession_number":"0001628280-24-028686","cik":1816708,"company_name":"Owlet, Inc.","ticker":"OWLT","form_type":"8-K","filed_at":"2024-06-18T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Owlet sets Aug 16, 2024 annual meeting; stockholder proposal deadline June 28, 2024","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Board set August 16, 2024 as date for 2024 annual meeting of stockholders.","Record date for stockholders entitled to vote is June 27, 2024.","Stockholder proposals under Rule 14a-8 must be received by June 28, 2024.","Deadline for proposals per Bylaws remains unchanged from prior proxy.","Time and location to be specified in the proxy statement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":166176689.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":230048,"accession_number":"0001628280-24-020617","cik":1816708,"company_name":"Owlet, Inc.","ticker":"OWLT","form_type":"8-K","filed_at":"2024-05-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Owlet Q1 revenue $14.8M (+37% YoY); net income $3.3M vs loss $11.9M YoY","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Gross margin 44.4%, up 570 bps YoY; adjusted EBITDA loss improved 46% to $3.1M.","Consumer sell-through demand for Dream Sock/Dream Duo up 60% YoY following FDA clearance.","Basic EPS $0.15 vs ($1.54) YoY; diluted net loss per share ($0.51).","Over 2 million infants monitored; NPS and reimbursement coverage expanding.","Cost of revenues $8.2M; operating expenses down to $12.3M from $15.1M YoY."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.51,"consensus_revenue_estimate":null,"consensus_revenue_actual":14750000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":166176689.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":248490,"accession_number":"0001628280-24-009645","cik":1816708,"company_name":"Owlet, Inc.","ticker":"OWLT","form_type":"8-K","filed_at":"2024-03-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Owlet Q4 revenue $21M, net loss down 65% YoY; FY23 gross margin up 810 bps","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue ~$21.0M; gross margin 47.1%; net loss ~$6.9M vs $19.5M YoY.","FY 2023 revenue ~$54.0M (down from $69.2M in 2022); gross margin 41.8% (up from 33.7%).","Adjusted EBITDA loss Q4 ~$0.7M (down 95% YoY); FY ~$16.3M (down 76% YoY).","CEO cites two FDA authorizations, commercializing medical devices, and expanding healthcare distribution.","Net loss per share FY 2023 $4.53 compared to $9.98 in 2022."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":166176689.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":248489,"accession_number":"0001628280-24-008342","cik":1816708,"company_name":"Owlet, Inc.","ticker":"OWLT","form_type":"8-K","filed_at":"2024-03-04T23:59:59+00:00","items":["3.03","5.03","9.01"],"status":"ready","headline":"Owlet raises $9.25M via Series B Convertible Preferred and warrants","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Sold 9,250 Series B Convertible Preferred shares and warrants for 1,799,021 Class A common shares, aggregate $9.25M.","Closing on Feb 29, 2024, per Investment Agreement dated Feb 25, 2024.","Certificate of Designation filed with Delaware sets conversion, liquidation, and voting terms for Series B Preferred.","Private placement modifies existing security holders' rights due to new series preferences."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":166176689.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":248488,"accession_number":"0001628280-24-006737","cik":1816708,"company_name":"Owlet, Inc.","ticker":"OWLT","form_type":"8-K","filed_at":"2024-02-26T23:59:59+00:00","items":["1.01","2.02","9.01","3.02","3.03","5.03","5.07","7.01"],"status":"ready","headline":"Owlet raises $9M in private placement of Series B preferred and warrants; Q4 preliminary results strong","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Gross proceeds $9M from sale of Series B convertible preferred and warrants; expected close Feb 28.","Conversion and exercise price reflect 25% premium to Feb 23 close; warrants at $7.7125, 5-year term.","Cash and equivalents over $16M at year-end; capital to fund commercialization of new FDA-cleared devices.","Existing investors Eclipse, Trilogy, and board member John Kim participated; resale S-1 to be filed.","Preliminary Q4 2023 results cited as strong but no revenue or EPS figures disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":166176689.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":248487,"accession_number":"0001628280-24-006167","cik":1816708,"company_name":"Owlet, Inc.","ticker":"OWLT","form_type":"8-K","filed_at":"2024-02-22T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Owlet prelim Q4 revenue $21M (+75% YoY), net loss down 65%, adj EBITDA near breakeven","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 gross sales ~$32.9M, up 114% YoY; net revenue ~$21.0M, up 75% YoY.","Gross margin ~47%, up from 27.8% YoY (over 1,900 bps improvement).","Net loss ~$6.9M, down 65% from $19.5M YoY; adj EBITDA loss ~$0.7M, down 95%.","CEO cites FDA clearances, new medical devices, insurance integration for 2024 momentum.","Excluding Amazon 1P transition items, gross margin >50% and adj EBITDA positive for Q4."],"consensus_eps_estimate":null,"consensus_eps_actual":-4.53,"consensus_revenue_estimate":null,"consensus_revenue_actual":54010000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":166176689.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":265989,"accession_number":"0001628280-23-038605","cik":1816708,"company_name":"Owlet, Inc.","ticker":"OWLT","form_type":"8-K","filed_at":"2023-11-13T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Owlet Q3 2023 revenue $9.2M, net loss $5.6M; FDA clears Dream Sock OTC","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 revenue $9.2M, down 47% YoY due to shift to Amazon first-party seller; sell-in shifted to Q4.","Net loss narrowed to $5.6M ($0.84/sh) from $19.4M ($2.42/sh) in Q3 2022.","Gross margin improved to 36.3% from 26.6%; operating expenses cut to $11.2M from $26.4M.","FDA de novo authorization for Dream Sock as first OTC pulse oximeter for healthy infants; launch by Dec 2023.","BabySat monitoring system market introduction began; commercial launch target by end of 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":-3.56,"consensus_revenue_estimate":null,"consensus_revenue_actual":33006000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":166176689.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":265988,"accession_number":"0001628280-23-038331","cik":1816708,"company_name":"Owlet, Inc.","ticker":"OWLT","form_type":"8-K","filed_at":"2023-11-09T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Owlet receives FDA de novo clearance for Dream Sock as first OTC infant pulse oximeter","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["FDA-cleared Dream Sock monitors pulse rate and oxygen saturation for healthy infants 1-18 months, 6-30 lbs.","Device provides Health Notifications with lights and alarms when readings fall outside preset ranges.","Medical-grade features to roll out to existing and new Dream Sock users by end of 2023 (U.S. only).","Follows prior FDA clearance of prescription BabySat system; Dream Sock now available without prescription.","CEO calls it a 'significant breakthrough' in at-home infant care and commitment to innovation."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":166176689.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":283219,"accession_number":"0001628280-23-029667","cik":1816708,"company_name":"Owlet, Inc.","ticker":"OWLT","form_type":"8-K","filed_at":"2023-08-16T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Owlet appoints Eclipse Investment Partner Marc Stoll to board, replacing Jayson Knafel","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Director Jayson Knafel resigned Aug 11, 2023 to become CFO of an unaffiliated company; no disagreement with Owlet.","Board appointed Marc Stoll (Eclipse Investment Partner) as Class II director effective Aug 15, 2023.","Stoll's background includes President/COO of Nextiva, CFO of Anaplan, and VP Worldwide Sales Finance at Apple.","Stoll fills Eclipse's designated board seat per the February 2023 Stockholders Agreement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":166176689.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":283218,"accession_number":"0001628280-23-029357","cik":1816708,"company_name":"Owlet, Inc.","ticker":"OWLT","form_type":"8-K","filed_at":"2023-08-14T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Owlet announces Q2 2023 results; press release text incomplete – no specific figures available","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Filing states press release for Q2 2023 results furnished as Exhibit 99.1.","Exhibit text in this filing is truncated; revenue, EPS, and segment detail are not extractable.","Investors should refer to the full press release on Owlet's investor relations website."],"consensus_eps_estimate":null,"consensus_eps_actual":-2.73,"consensus_revenue_estimate":null,"consensus_revenue_actual":23824000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":166176689.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":283217,"accession_number":"0001628280-23-026273","cik":1816708,"company_name":"Owlet, Inc.","ticker":"OWLT","form_type":"8-K","filed_at":"2023-07-31T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Owlet appoints Jonathan Harris as President and Chief Revenue Officer","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Jonathan Harris appointed effective July 25, 2023; Kurt Workman remains CEO.","Annual base salary of $375,000 plus target cash bonus of 50% of salary.","Received initial RSU grant of $600,000, with second tranche of $400,000 at 6-month anniversary.","Harris previously scaled GoPro from $19M to $1.5B in revenue and led Molekule/ AeroClean merger.","Appointment follows recent FDA clearance for BabySat pulse-oximetry device."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":166176689.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":283216,"accession_number":"0001628280-23-025334","cik":1816708,"company_name":"Owlet, Inc.","ticker":"OWLT","form_type":"8-K","filed_at":"2023-07-21T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Owlet appoints Melissa Gonzales to board; brings women's health and consumer healthcare expertise","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Melissa Gonzales appointed as Class I director effective July 18, 2023, term expiring at 2025 annual meeting.","Gonzales is President, Women's Health at Myriad Genetics (MYGN) and brings 20+ years healthcare experience.","She will receive annual cash retainer of $50k and initial RSU grant valued ~$150k prorated.","Owlet CEO cites Gonzales' expertise as key as company prepares to launch BabySat FDA-cleared pulse oximetry device.","Gonzales also serves as Board Chair of March of Dimes, Chicago."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":166176689.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":283215,"accession_number":"0001628280-23-024723","cik":1816708,"company_name":"Owlet, Inc.","ticker":"OWLT","form_type":"8-K","filed_at":"2023-07-11T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Owlet announces NYSE acceptance of compliance plan; cure period extended 18 months","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["NYSE accepted Owlet's business plan to regain compliance with continued listing standards under Section 802.01B.","Company has 18-month cure period from April 4, 2023 to meet $50M market cap or stockholders' equity threshold.","1-for-14 reverse stock split effective July 7, 2023 to address minimum $1.00 average closing price requirement.","FDA clearance of BabySat medical pulse-oximetry device cited as growth catalyst."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":166176689.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":283214,"accession_number":"0001628280-23-024574","cik":1816708,"company_name":"Owlet, Inc.","ticker":"OWLT","form_type":"8-K","filed_at":"2023-07-07T23:59:59+00:00","items":["3.03","5.03","8.01","9.01"],"status":"ready","headline":"Owlet announces 1-for-14 reverse stock split effective July 7; shares to trade on split-adjusted basis July 10","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Reverse split reduces outstanding Class A common stock from ~118M to ~8.4M shares.","Authorized Common Stock reduced from 1B to ~107M shares; preferred authorized cut from ~100M to ~10.7M.","Move intended to help regain NYSE $1.00 minimum average closing price compliance.","No fractional shares; cash paid in lieu; CUSIP changes to 69120X206.","NYSE previously halted and delisted Owlet's warrants due to low trading price."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":166176689.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":302632,"accession_number":"0001628280-23-023805","cik":1816708,"company_name":"Owlet, Inc.","ticker":"OWLT","form_type":"8-K","filed_at":"2023-06-28T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Owlet stockholders approve reverse stock split and Eclipse ownership proposal at 2023 annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Elected directors Jayson Knafel and Kurt Workman to Class II board seats through 2026.","Approved reverse stock split at ratio of 1-for-10 to 1-for-20, with Board to set final ratio.","Approved change-of-control issuance of common stock upon conversion of Series A preferred and warrants to Eclipse Ventures LLC.","Ratified PricewaterhouseCoopers as independent auditor for FY 2023 with 102.4M votes for."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":166176689.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":302631,"accession_number":"0001628280-23-023003","cik":1816708,"company_name":"Owlet, Inc.","ticker":"OWLT","form_type":"8-K","filed_at":"2023-06-22T23:59:59+00:00","items":["3.01","8.01"],"status":"ready","headline":"Owlet receives FDA clearance for BabySat pulse-ox; NYSE commences warrant delisting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["FDA cleared BabySat, first medical pulse-ox device with wire-free sock design; US launch expected later in 2023.","NYSE halted trading in Owlet warrants (OWLT.WS) due to low price; moves to delist citing 'abnormally low' price levels.","Company will not appeal warrant delisting; common stock (OWLT) trading on NYSE unaffected."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":166176689.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":302630,"accession_number":"0001628280-23-017551","cik":1816708,"company_name":"Owlet, Inc.","ticker":"OWLT","form_type":"8-K","filed_at":"2023-05-11T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Owlet issues Q1 2023 earnings press release; financial details not available in filing excerpt","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Press release dated May 11, 2023, reporting results for three months ended March 31, 2023.","Exhibit 99.1 is furnished but the text provided is truncated; no specific figures are included.","The filing does not contain revenue, EPS, or any other financial metrics for the quarter."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.11,"consensus_revenue_estimate":null,"consensus_revenue_actual":10736000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":166176689.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":302629,"accession_number":"0001628280-23-011179","cik":1816708,"company_name":"Owlet, Inc.","ticker":"OWLT","form_type":"8-K","filed_at":"2023-04-10T23:59:59+00:00","items":["3.01","7.01","9.01"],"status":"ready","headline":"Owlet receives NYSE delisting notice for low market cap and equity","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["NYSE notified Owlet on April 4, 2023, that its average market cap and stockholders' equity were both below $50 million (Section 802.01B).","Company plans to submit a cure business plan within 45 days; NYSE has 18-month cure period to review compliance.","No immediate impact on stock listing; if plan accepted, trading continues under NYSE monitoring.","Owlet also faces a prior NYSE deficiency (November 2022) for share price below $1.00; still in six-month cure period."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":166176689.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":322287,"accession_number":"0001628280-23-010140","cik":1816708,"company_name":"Owlet, Inc.","ticker":"OWLT","form_type":"8-K","filed_at":"2023-03-31T23:59:59+00:00","items":["1.01","5.02","9.01"],"status":"ready","headline":"Owlet amends SVB loan, defers principal payments, waives defaults, reduces liquidity covenant to $15M","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Deferred principal payments from March 1, 2023 through August 1, 2023; repayments resume September 1, 2023 at $500k/month plus interest.","Waived stated events of default for failing minimum liquidity and net revenue covenants; liquidity threshold reduced from $25M to $15M.","Replaced minimum net revenue covenants with adjusted EBITDA covenants; expanded eligible inventory and accounts borrowing base.","Chief Accounting Officer Nathaniel Yoo resigned effective March 31, 2023; CFO Kathryn Scolnick appointed as principal accounting officer.","Paid $50k waiver fee; deferred additional fee; term loan maturity extended to October 1, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":166176689.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":322286,"accession_number":"0001628280-23-008100","cik":1816708,"company_name":"Owlet, Inc.","ticker":"OWLT","form_type":"8-K","filed_at":"2023-03-15T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Owlet issues press release for Q4/FY2022 results; financial details unavailable in provided text","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Owlet announced Q4 and FY2022 results via press release on March 15, 2023.","Specific financial figures (EPS, revenue, guidance) were not extractable from the truncated exhibit.","The filing confirms the press release was issued; no further data is available in the provided document."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":166176689.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":322285,"accession_number":"0001628280-23-004142","cik":1816708,"company_name":"Owlet, Inc.","ticker":"OWLT","form_type":"8-K","filed_at":"2023-02-21T23:59:59+00:00","items":["1.01","3.02","3.03","5.02","5.03","7.01","9.01"],"status":"ready","headline":"Owlet raises $30M via Series A convertible preferred and warrants; appoints new director","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["$30M gross proceeds from private placement of Series A convertible preferred stock and warrants.","Preferred shares convertible into ~61.2M common shares; warrants for 110.2M shares at $0.333.","Eclipse Ventures affiliates purchased $20.2M; other existing investors including CEO Workman participated.","Board expanded to seven; Eclipse designee Jayson Knafel appointed as Class II director.","Proceeds for general corporate purposes and strategic initiatives; Cowen acted as placement agent."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":166176689.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":340330,"accession_number":"0001628280-22-032483","cik":1816708,"company_name":"Owlet, Inc.","ticker":"OWLT","form_type":"8-K","filed_at":"2022-12-22T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"FDA accepts Owlet's de novo submission for Health Notifications SaMD for heart rate and oxygen","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["FDA accepted for substantive review Owlet's de novo classification request for over-the-counter SaMD 'Health Notifications'.","Health Notifications would provide live heart rate and oxygen saturation displays and notifications via Dream Sock.","This is Owlet's second FDA submission in 2022; first was a 510(k) for a prescription monitor in October.","CEO Kurt Workman stated FDA authorization could uniquely position Owlet to help caregivers with live health data.","De novo pathway is for low-to-moderate risk devices with no legally marketed predicate."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":166176689.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":340329,"accession_number":"0001628280-22-031415","cik":1816708,"company_name":"Owlet, Inc.","ticker":"OWLT","form_type":"8-K","filed_at":"2022-12-06T23:59:59+00:00","items":["3.01","7.01","9.01"],"status":"ready","headline":"Owlet receives NYSE non-compliance notice for stock price below $1.00","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["NYSE notified Owlet on Nov 29, 2022 that average closing price was below $1.00 for 30 consecutive trading days.","Company has a six-month cure period to regain compliance with NYSE continued listing standards.","Options to cure include a reverse stock split, subject to stockholder approval no later than next annual meeting.","No immediate impact on listing; common stock and warrants continue trading on NYSE during cure period."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":166176689.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2022-12-06T23:59:59+00:00|340329"}